ArticleNature communications2024

Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy.

Zaid Taha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.